0111 4Q20 Wrap
BioCentury & Getty Images

Finance

4Q20 Wrap: Stocking up

All market cap tiers were up in 4Q and FY20

All market cap tiers were up in 4Q and FY20

Jan 9, 2021 | 4:18 AM GMT

Life sciences stocks continued an upward trajectory at the end of 2020, with median gains of at least 7% in 4Q20 and at least 24% over the year across all market cap tiers. Companies valued between $500-$999 million were the best performers during the last quarter with a median gain of

Read the full 853 word article

How to gain access

Continue reading with a
two-week free trial.